DOMINANT ROLE OF E-CADHERIN IN THE PROGRESSION OF BLADDER CANCER
Authors:
- 1 February 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (2) , 692-698
Abstract
Conclusions These results implicate loss of E-cadherin expression as a critical factor in facilitating the progression of bladder cancer.Keywords
This publication has 18 references indexed in Scilit:
- Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinomaBritish Journal of Cancer, 1996
- E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survivalInternational Journal of Cancer, 1995
- Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA)International Journal of Cancer, 1995
- Over‐expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinomaInternational Journal of Cancer, 1995
- The Content of Urokinase-Type Plasminogen Activator and Tumor Recurrence in Superficial Bladder CancerJournal of Urology, 1994
- Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcriptionBritish Journal of Cancer, 1992
- E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.Journal of Cell Biology, 1991
- Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: Increased PA activity correlates with biologically aggressive behaviorThe Prostate, 1991
- Specific Detection of Metastasized Human Tumor Cells in Embryonic Chicks by the Polymerase Chain ReactionJapanese Journal of Cancer Research, 1990
- IN VITRO CULTURE OF MALIGNANT TUMOR TISSUES FROM THE HUMAN URINARY TRACTThe Japanese Journal of Urology, 1977